What licenses regulate home care in Massachusetts?

Home health agencies in Massachusetts are licensed by the Department of Public Health (DPH) under 105 CMR 158. Hospice agencies are separately licensed. Non-medical home care companies are not separately licensed at the state level but must comply with consumer protection registration under the Home Care Service Provider statute through the Office of the Attorney General.

Is Massachusetts a CON state for home health?

Yes, in part. Massachusetts has a Determination of Need (DoN) framework that applies to many healthcare facility expansions. Home health agency creation has historically been more accessible than hospital DoN, but the regulated environment limits buyer options for organic entry. Existing licenses carry strategic value.

What is MassHealth ACO and how does it affect home care valuation?

MassHealth ACO is the state Medicaid Accountable Care Organization model. Most MassHealth members are enrolled in ACOs that contract with home care providers under value-based and fee-for-service arrangements. Agency contracts with Senior Care Options (SCO) plans, One Care plans, and PACE programs are also significant value drivers. Buyer diligence focuses heavily on the breadth and economics of these managed-care relationships.

What are typical home care EBITDA multiples in Massachusetts in 2026?

Personal care with strong managed care contracts: 5.5x–8x for $1M–$3M EBITDA, 7.5x–10x for $3M+ EBITDA platforms. Medicare-certified home health: 7.5x–10.5x for sub-$3M EBITDA, 9.5x–12.5x for larger platforms. Hospice: 9x–13x. Behavioral health: 8x–12x. Premium pricing applies to platforms with diversified ACO/SCO contracts and strong outcomes data.

Selling a Home Care Agency in Massachusetts 2026

Massachusetts is a high-acuity, managed-care-dominated home care market with one of the most sophisticated payer environments in the country. The combination of MassHealth ACO contracting, Senior Care Options, One Care for dual eligibles, PACE, and a strong commercial managed-care presence creates an environment where contract sophistication and outcomes documentation drive valuation as much as headline EBITDA.

This guide covers what Massachusetts agency owners should understand about selling in 2026.

Why Massachusetts Is a Distinct M&A Market

Sophisticated payer environment. Massachusetts pioneered ACO contracting and value-based care; agencies operating in MA are typically more sophisticated in outcomes documentation than national averages.

High labor cost / margin compression. MA caregiver wages are among the highest in the country, compressing operating margins. Buyers value agencies with proven labor cost discipline.

Limited DoN pipeline for some asset types. While not as restrictive as NY, MA’s regulatory environment limits new entrants in certain segments.

Strong demographic tailwind. Massachusetts has one of the highest senior population concentrations in the Northeast.

Active strategic buyer presence. MA-based and Northeast-focused strategic operators (BAYADA, Compassus-affiliated, Care Dimensions, Regional Hospice, others) actively acquire in-state.

License and Regulatory Structure

Home Health Agency (DPH licensure under 105 CMR 158)

Skilled home health (nursing, therapy, social work, home health aide)
Medicare and MassHealth certified pathways
Subject to DPH survey and certification

Hospice License

Separate DPH licensure
Medicare-certified pathway typical
Hospice multiples in MA are at the high end of national ranges

Non-Medical Home Care

No DPH licensure required
Must register as Home Care Service Provider with the Office of the Attorney General
Subject to AGO consumer protection regulations
Workers’ compensation, wage-and-hour, and PTO accrual compliance heavily enforced

Behavioral Health

DPH licensure pathways for BH services
Department of Mental Health (DMH) contracts for some populations
Bureau of Substance Addiction Services (BSAS) for SUD

The Managed Care Environment

Massachusetts payer dynamics are central to home care valuation. Buyers focus on:

MassHealth ACO contracts — prevalence, plan partners (Mass General Brigham, BMC HealthNet, Tufts, Fallon, others), value-based provisions
Senior Care Options (SCO) contracts — Commonwealth Care Alliance, Tufts Health Plan SCO, others
One Care contracts — for dual eligibles
PACE program participation — where applicable
Commercial managed care — Blue Cross Blue Shield of MA, Harvard Pilgrim, Tufts, Mass General Brigham Health Plan
MassHealth FFS residual revenue

Sellers with diversified contract portfolios trade at premium multiples. Single-plan dependence is a meaningful valuation negative.

Typical Massachusetts Home Care Valuation Ranges (Q2 2026)

Asset Type	EBITDA Size	Multiple Range
Personal care (strong MC mix)	$1M–$3M	5.5x–8x
Personal care (strong MC mix)	$3M–$10M	7.5x–10.5x
Personal care (large platform)	$10M+	9x–12x
Medicare home health	sub-$3M	7.5x–10.5x
Medicare home health	$3M+	9.5x–12.5x
Hospice	sub-$3M	8.5x–11.5x
Hospice	$3M+	10x–13.5x
Behavioral health / SUD	$2M–$10M	8x–12x

Buyer Landscape

Strategic Buyers Active in Massachusetts

BAYADA Home Health Care
Compassus — Hospice
Care Dimensions — Regional hospice
Element Care, ESCC — PACE-affiliated
Commonwealth Care Alliance — affiliated providers
Multiple regional MA-based home care platforms
National platforms with NE focus (BrightSpring, Help at Home, Aveanna)

PE Platforms with Active MA Mandates

Webster Equity Partners (HQ in Waltham — particularly active in MA)
Linden Capital, Charlesbank
Multiple Boston-area PE and family office buyers

Common Massachusetts Seller Mistakes

1. Underestimating wage-and-hour exposure. MA has aggressive enforcement; pre-sale audit is essential.

2. Disorganized ACO/SCO contract documentation. Buyers need to underwrite each contract individually.

3. Single-plan concentration without remediation. ACO mix diversification is a multi-quarter exercise.

4. Single-buyer outreach. MA’s deep buyer pool rewards competitive process.

How Hendon Partners Helps Massachusetts Sellers

Hendon Partners advises MA home care, home health, hospice, and behavioral health agency owners through preparation, sale process, and close — with deep familiarity in MassHealth ACO, SCO, One Care, PACE, and commercial managed care dynamics.

Schedule a confidential MA-focused conversation with Hendon Partners →

Hendon Partners is a sell-side only home care M&A advisory firm with Massachusetts transaction experience.

Selling a Home Care Agency in Massachusetts: 2026 Market Guide